期刊文献+

p53抗原肽及B7重组痘苗病毒抗肿瘤的研究 被引量:1

Antitumor Responses Induced by Recombinant Vaccinia Viruses Expressing p53 Antigenic Peptide and B7
下载PDF
导出
摘要 目的 :探索点突变 p5 3抗原肽重组痘苗病毒诱导的抗瘤免疫效应 ,以及B7对之的加强作用 ,为重组抗原肽疫苗用于肿瘤免疫治疗提供实验依据。方法 :选择人 135位Cys→Tyr点突变p5 3为肿瘤相关抗原模型 ,观察包含该点突变p5 3抗原肽p5 312 5~ 14 5的重组痘苗病毒rVV p5 3M 单独和联合应用表达B7的重组痘苗病毒rVV B7诱导的CTL及对荷瘤小鼠的免疫保护和治疗效应。结果 :以rVV p5 3M 经静脉免疫BALB/c小鼠能够诱导以CD8+ T细胞为主的特异性CTL。rVV p5 3M 能够保护部分小鼠免遭致死剂量的肿瘤细胞攻击。以rVV p5 3M 治疗荷瘤小鼠 ,可显著延长小鼠平均存活时间。rVV B7与rVV p5 3M 以 1∶1的比例混合接种可加强rVV p5 3M诱导的抗瘤免疫反应。结论 :以痘苗病毒为载体的p5 3抗原肽疫苗可代替人工合成抗原肽 ,有潜在的临床应用价值 ,共刺激分子B7与肿瘤抗原相结合是一种有效的免疫治疗策略。 Objective: To explore antitumor responses induced by recombinant vaccinia viruses expressing a p53 antigenic peptide (rVV p53 M) and enhanced effect of recombinant vaccinia viruses expressing costimulatory molecule B7 (rVV B7). Methods: A 135 Cys to Tyr point mutation p53 transduced P815 mastocytoma (P815 mp53) was used as an experimental tumor and the p53 protein as the model of tumor associated antigen. rVV p53 M and rVV B7 were used as vaccine to test their induction of CTL and antitumor immunity. Results: Immunization of BABL/c mice with rVV p53 M could elicit specific CTLs, which could specifically lyse P815 mp53 cells. Immunization of mice with rVV p53 M could survive a part of mice challenged with 1×10 6 P815 mp53. Treatment with rVV p53 M could significantly prolong the survival of tumor bearing mice. Admixture at 1∶1 ratio of rVV p53 M and rVV B7 could enhance antitumor responses induced by rVV p53 M. Conclusion: Immunization with recombinant vaccinia virus expressing antigenic peptide is a useful alternative to peptide based vaccine. Costimulatory molecule B7 can enhance antigenic peptide to induce antitumor responses.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2000年第4期261-264,共4页 Chinese Journal of Cancer Biotherapy
关键词 P53 抗原肽 B7 重组痘苗病毒 肿瘤 免疫治疗 p53 antigenic peptide B7 recombinant vaccinia virus tumor
  • 相关文献

参考文献7

  • 1[1]McCabe BJ, Irvine KR, Nishimura MI, et al. Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses. Cancer Res, 1995, 55(8): 1741
  • 2[2]Hodge JW, Abrams S, Schlom J, et al. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res, 1994, 54(21 ): 5552
  • 3[3]Mackett M, Smith GL, Moss B. Vaccinia virus: A selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci USA, 1982,79 (23): 7415
  • 4[4]Restifo NPF, Bacik I, hvine KR, et al. Antigen processing ia vivo and the elicitation of primary CTL responses. J Immunol, 1995, 154:4414
  • 5[5]Wang M, Bronte V, Chen PW, et al. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J Immunol, 1995, 154(9):4685
  • 6[6]Soussi T. The humoral response to the tumor-suppressor gene-product p53 in human cancer: Implications for diagnosis and therapy. Immunol Today, 1996, 17(8): 354
  • 7[7]Chamberlain RS, Carroll MW, Bronte V, et al. Costimulation enhances the active immnnotherapy effect of recombinant anticancer vaccines. Cancer Res, 1996, 56(12): 2832

同被引文献28

  • 1丛华,古钦民,周怀瑜,李瑛,何深一,赵群力,王静雯.弓形虫多价DNA疫苗免疫途径与效果评价[J].中国公共卫生,2006,22(1):56-57. 被引量:4
  • 2范骏,谢勇(审校者).肠道黏膜免疫[J].国际免疫学杂志,2006,29(2):111-115. 被引量:33
  • 3刘智英,诸欣平,杨雅平,李强,顾园.旋毛虫Ts87重组蛋白诱导的小鼠黏膜免疫保护性研究[J].寄生虫与医学昆虫学报,2006,13(4):208-211. 被引量:4
  • 4Wittig BM, Zeitz M. The gut as an organ of immunology[J]. Inter- national journal of colorectal disease, 2003, 18(3) : 181-187.
  • 5Newberry RD, Lorenz RG. Organizing a mucosal defense[J]. Immunol Rev, 2005, 206(1): 6-21.
  • 6Kraehenbuhl JP, Corbett M. Immunology: keeping the gut microflora at bay[J]. Science, 2004, 303(5664): 1624-1625.
  • 7Kasper L, Courret N, Darche S, et al. Toxoplas magondii and mucosal immunity[J]. Int J Parasitol, 2004, 34(3): 401-409.
  • 8DimierPoisson I, Aline F, Bout D, et al. Induction of protective immunity against toxoplas mosisinmice by immunization with Toxo- plas magondii RNA[J]. Vaccine, 2006, 24(10): 1705-1709.
  • 9Fynan EF, Webster RG, Fuller DH, et al. DNA vaccine: protec- tive immunization by parenteral, mucosal, and gene-gun inocula- tions[J]. Proc Natl Acad Sci U S A, 1993, 90(3) : 11478-11482.
  • 10Pertmer TM, Roberts TR, Haynes JR. Influenza virus nucleopro- tein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery[J]. J Virol, 1996, 70(9): 6119-6125.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部